论文信息 - Reply to Muntean et al. Comment on “Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482” - 字舞流文

Reply to Muntean et al. Comment on “Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482”

We appreciate the interest in our publication and agree that a different acronym for the method would have been better [...].

M. Kundi | I. Barišić | D. Mitteregger | B. Bedenić | D. Kosak | J. Wessely

[1] T. Naas,et al. Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482 , 2022, Pathogens.

[2] M. Kundi,et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A , 2022, Pathogens.

[3] T. Naas,et al. Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers. , 2021, The Journal of antimicrobial chemotherapy.

[4] B. Limbago,et al. Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii , 2017, Journal of Clinical Microbiology.

[5] R. Thomson,,et al. Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae , 2017, Journal of Clinical Microbiology.

[6] T. Naas,et al. Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae , 2017, PloS one.

[7] C. Walsh,et al. Antibiotics: Challenges, Mechanisms, Opportunities , 2016 .

[8] L. Schouls,et al. The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods , 2015, PloS one.